Acute hepatitis B caused by a vaccine-escape HBV strain in vaccinated subject: Sequence analysis and therapeutic strategy

Journal of Clinical Virology

Volumn 62, Issue , 2015, Pages 89-91

  Luongo, Monica ^a   Critelli, Rosina ^a   Grottola, Antonella ^b   Gitto, Stefano ^a   Bernabucci, Veronica ^a   Bevini, Mirco ^c   Vecchi, Chiara ^c   Montagnani, Giuliano ^c   Villa, Erica ^a  

^a Gastroenterology Unit   (Italy)

^b Laboratory Services and Legal Medicine ^*  (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Acute hepatitis; Escape mutant; Hepatitis B virus; Telbivudine; Vaccine

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; TELBIVUDINE; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIGENICITY; ARTHRALGIA; ARTICLE; BLOOD DONOR; CASE REPORT; CAUCASIAN; DRUG WITHDRAWAL; FEVER; HEPATITIS B; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; NAUSEA; POINT MUTATION; RISK FACTOR; SEQUENCE ANALYSIS; VACCINE FAILURE; VIRUS STRAIN; ADVERSE EFFECTS; AMINO ACID SEQUENCE; CHEMISTRY; GENETICS; GENOTYPE; HEPATITIS B VIRUS; IMMUNOLOGY; MOLECULAR GENETICS; MUTATION; SEQUENCE ALIGNMENT; VACCINATION; VIROLOGY;

AMINO ACID SEQUENCE; GENOTYPE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; SEQUENCE ALIGNMENT; VACCINATION;

EID: 84920452320     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2014.11.029     Document Type: Article

References (14)

1. Carman W.F., Zanetti A.R., Karayiannis P., Waters J., Manzillo G., Tanzi E., et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990, 336:325-329. 10.1016/0140-6736(90)91874-A.
2. Tallo T., Tefanova V., Priimägi L., Schmidt J., Katargina O., Michailov M., et al. D2:major subgenotype of hepatitis B virus in Russia and the Baltic region. J Gen Virol 2008, 89:1829-1839. 10.1099/vir.0.83660-0.
3. Chiou H.L., Lee T.S., Kuo J., Mau Y.C., Ho M.S. Altered antigenicity of 'a' determinant variants of hepatitis B virus. J Gen Virol 1997, 78:2639-2645.
4. Rodríguez-Nóvoa S., Gómez-Tato A., Aguilera-Guirao A., Castroagudín J., González-Quintela A., Garcia-Riestra C., et al. Hepatitis B virus genotyping based on cluster analysis of the region involved in lamivudine resistance. J Virol Methods 2004, 115:9-17. 10.1016/j.jviromet.2003.08.011.
5. Grottola A., Buttafoco P., Villa E., Cremonini C., Colantoni A., Gelmini R., et al. Pretransplantation pre-S2 and S protein heterogeneity predisposes to HBV recurrence after liver transplantation. Liver Transpl 2002, 8:443-448. 10.1053/jlts.2002.32719.
6. Ghosh S., Banerjee P., Choudhury A.R., Sarkar S., Ghosh A., Santra A., et al. Unique hepatitis B virus subgenotype in a primitive tribal community in eastern India. J Clin Microbiol 2010, 48:4063-4071.
7. Zhou B., Xiao L., Wang Z., Chang E.T., Chen J., Hou J., et al. Geographical and ethnic distribution of the HBV C/D recombinant on the Qinghai-Tibet plateau. PLoS ONE 2011, 6:E18708.
8. Mostert M., De Man R.R.A., Niesters B.H.G.M., Van Doornum G.G.J.J., Götz H.H.M., Richardus J.J.H., et al. The added value of molecular analysis in the source and contact tracing of hepatitis B transmission in a community. J Clin Virol 2006, 36:S13.
9. Ma Q., Wang Y. Comprehensive analysis of the prevalence of HBV escape mutations in the major hydrophilic region of surface antigen. J Med Virol 2012, 84:198-206. 10.1002/jmv.23183.
10. Coleman P.F., Chen Y.C., Mushahwar I.K. Immunoassay detection of hepatitis B surface antigen mutants. J Med Virol 1999, 59:19-24. 10.1002/(SICI)1096-9071(199909)59:1<19::AID-JMV4>3.0.CO;2-B.
11. Koyanagi T., Nakamuta M., Sakai H., Sugimoto R., Enjoji M., Koto K., et al. Analysis of HBs antigen negative variant of hepatitis B virus: unique substitutions, Glu129-to-Asp and Gly145-to-Ala in the surface antigen gene. Med Sci Monit 2000, 6:1165-1169.
12. Chackerian B., Rudensey L.M., Overbaugh J. Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus that evolve in the host alter recognition by neutralizing antibodies. J Virol 1997, 71:7719-7727.
13. Ljaz S., Ferns R.B., Tedder R.S. A 'first loop' linear epitope accessible on native hepatitis B surface antigen that persists in the face of 'second loop' immune escape. J Gen Virol 2003, 84:269-275. 10.1099/vir.0.18667-0.
14. Wu Z.G., Yan W.M., Guo W., Chen T., Zou Y., Wang H.W., et al. Telbivudine preserves T-helper 1 cytokine production and downregulates programmed death ligand 1 in a mouse model of viral hepatitis. J Viral Hepat 2010, 17(Suppl. 1):24-33. 10.1111/j.1365-2893.2010.01268.x.